APA (7th ed.) Citation

Kardjadj, M., Priestly, I. P., Chavez, R., Derrick, D., & Huard, T. K. (2025). Clinical Symptom Resolution Following PCR-Guided vs. Culture and Susceptibility-Guided Management of Complicated UTI: How Time-To-Antibiotic Start and Antibiotic Appropriateness Mediate the Benefit of Multiplex PCR—An Ad Hoc Analysis of NCT06996301. Diagnostics (2075-4418), 15(24), 3107. https://doi.org/10.3390/diagnostics15243107

Chicago Style (17th ed.) Citation

Kardjadj, Moustafa, Itoe P. Priestly, Roel Chavez, DeAndre Derrick, and Thomas K. Huard. "Clinical Symptom Resolution Following PCR-Guided Vs. Culture and Susceptibility-Guided Management of Complicated UTI: How Time-To-Antibiotic Start and Antibiotic Appropriateness Mediate the Benefit of Multiplex PCR—An Ad Hoc Analysis of NCT06996301." Diagnostics (2075-4418) 15, no. 24 (2025): 3107. https://doi.org/10.3390/diagnostics15243107.

MLA (9th ed.) Citation

Kardjadj, Moustafa, et al. "Clinical Symptom Resolution Following PCR-Guided Vs. Culture and Susceptibility-Guided Management of Complicated UTI: How Time-To-Antibiotic Start and Antibiotic Appropriateness Mediate the Benefit of Multiplex PCR—An Ad Hoc Analysis of NCT06996301." Diagnostics (2075-4418), vol. 15, no. 24, 2025, p. 3107, https://doi.org/10.3390/diagnostics15243107.